Effect of Helicobacter Pylori Eradication on Hepatic Steatosis of Children with Non-Alcoholic Fatty Liver Disease and Attending Alexandria University Children’s Hospital

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202212783625379

Enrollment

Registered

2022-12-12

Start date

2022-12-15

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System Paediatrics

Interventions

Concomitant therapy

Conventional treatment of fatty liver life style modifications

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Children meeting ultrasonic criteria of Non-alcoholic fatty liver disease .

Exclusion criteria

Exclusion criteria: Children with fatty liver disease due to other causes rather than Non-alcoholic fatty liver disease (e.g., viral hepatitis, celiac disease, metabolic liver diseases) are excluded

Design outcomes

Primary

Measure	Time frame
Fatty liver index;Hepatic steatosis index ;NAFLD liver fat score	—

Secondary

Measure	Time frame
Body mass index	—

Countries

Egypt

Contacts

Public ContactElsayedamr Basma

Patient Information Manager

elsayedamr@yahoo.com00201223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026